Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 350 (9072) , 161-165
- https://doi.org/10.1016/s0140-6736(97)06305-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993
- Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchusClinical Oncology, 1991
- Induction chemotherapy for non-small cell carcinoma of the lung: limitations and lessonsInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometryBritish Journal of Cancer, 1988
- Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancerRadiotherapy and Oncology, 1988
- Non-small-cell lung cancer: should unresectable stage III patients routinely receive high-dose radiation therapy?Journal of Clinical Oncology, 1988
- Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology groupCancer, 1987
- Primary tumor control after radiotherapy for carcinoma of the bronchusInternational Journal of Radiation Oncology*Biology*Physics, 1984
- The Survival of Patients with Inoperable Lung Cancer: A Large-Scale Randomized Study of Radiation Therapy Versus PlaceboRadiology, 1968